US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses. Our quality metrics help you find companies that generate superior returns on capital employed.
Integra LifeSciences Holdings Corporation (IART) is a medtech firm focused on surgical and regenerative medicine products, whose shares are currently trading at $10.84 as of April 16, 2026, marking a 1.72% decline from its prior closing price. This analysis breaks down key technical levels, recent market context for the stock, and potential short-term scenarios for traders and investors to monitor. No recent earnings data is available for IART as of this writing, so price action has been driven
Integra (IART) Stock Relative Weakness (Institutional Selling) 2026-04-16 - Quote Data
IART - Stock Analysis
4,170 Comments
1,072 Likes
1
Siara
Influential Reader
2 hours ago
This deserves to be celebrated. π
π 24
Reply
2
Tamilore
Expert Member
5 hours ago
A real star in action. β¨
π 215
Reply
3
Omariah
Legendary User
1 day ago
So much creativity in one project.
π 236
Reply
4
Yareni
New Visitor
1 day ago
Truly inspiring work ethic.
π 162
Reply
5
Cleofas
Registered User
2 days ago
A level of excellence thatβs hard to match.
π 186
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.